Abu Dhabi’s M42 Invests In Longevity Startup Juvenescence
Hasan Jasem Al Nowais
Source: M42This article is for subscribers only.
Abu Dhabi’s state-backed health-care investment company M42 has taken a stake in biotech startup Juvenescence, a UK-based firm focused on developing drugs to expand human lifespans.
M42, which was established through the combination of the health-care assets of two of Abu Dhabi’s investment firms, is investing an undisclosed amount into Juvenescence at a valuation of over $550 million, according to a statement.